Nicholas G Nickols Selected Research

Androgen Antagonists (Antiandrogens)

1/2023	Multimodality Therapies for Localized Prostate Cancer.
1/2017	A Pyrrole-Imidazole Polyamide Is Active against Enzalutamide-Resistant Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas G Nickols Research Topics

Disease

66	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 06/2007
21	Neoplasms (Cancer) 03/2024 - 10/2003
15	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2017
4	Adenocarcinoma 12/2023 - 01/2017
3	Disease Progression 11/2022 - 01/2018
3	Hypoxia (Hypoxemia) 08/2007 - 11/2004
2	Hypertension (High Blood Pressure) 01/2022 - 07/2021
2	COVID-19 01/2022 - 07/2021
1	AIDS-Related Complex (ARC) 07/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Infections 07/2021
1	Melanoma (Melanoma, Malignant) 12/2019
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Weight Loss (Weight Reduction) 10/2012
1	Leukemia 10/2003

Drug/Important Bio-Agent (IBA)

19	AndrogensIBA 03/2024 - 06/2007
15	AntigensIBA 04/2024 - 01/2018
11	Nylons (Nylon)IBA 01/2017 - 10/2003
10	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 06/2007
7	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 06/2007
7	Hormones (Hormone)IBA 03/2024 - 06/2007
5	gallium 68 PSMA-11IBA 01/2019 - 01/2018
4	PyrrolesIBA 01/2017 - 11/2004
4	imidazoleIBA 01/2017 - 11/2004
3	LigandsIBA 01/2018 - 05/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2004
3	A-Form DNA (A-DNA)IBA 10/2012 - 06/2007
2	Prednisone (Sone)FDA LinkGeneric 03/2024 - 04/2019
2	apalutamideIBA 03/2024 - 04/2019
2	Abiraterone AcetateIBA 03/2024 - 04/2019
2	Leuprolide (Lupron)FDA LinkGeneric 03/2024 - 04/2019
2	Testosterone (Sustanon)FDA Link 03/2024 - 01/2019
2	Androgen Antagonists (Antiandrogens)IBA 01/2023 - 01/2017
2	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 01/2022 - 07/2021
2	RNA (Ribonucleic Acid)IBA 05/2013 - 10/2012
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2007 - 10/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007 - 11/2004
1	Docetaxel (Taxotere)FDA Link 01/2023
1	abirateroneIBA 01/2023
1	GalliumIBA 01/2023
1	mesoglycanIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 07/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2021
1	pyridineIBA 11/2020
1	AcidsIBA 11/2020
1	trametinibIBA 12/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 12/2019
1	Antineoplastic Agents (Antineoplastics)IBA 04/2019
1	AntibodiesIBA 01/2018
1	FluoridesIBA 01/2018
1	Anti-Idiotypic AntibodiesIBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	fluoromethylcholineIBA 01/2018
1	enzalutamideIBA 01/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Estrogen Receptor alphaIBA 05/2013
1	LuciferasesIBA 05/2013
1	Estrogens (Estrogen)FDA Link 05/2013
1	Fluorescein-5-isothiocyanate (FITC)IBA 10/2012
1	Small Interfering RNA (siRNA)IBA 08/2007
1	EchinomycinIBA 08/2007

Therapy/Procedure

47	Radiotherapy 04/2024 - 07/2016
23	Therapeutics 03/2024 - 01/2013
18	Prostatectomy (Retropubic Prostatectomy) 03/2024 - 01/2017
8	Brachytherapy 01/2023 - 07/2016
4	Castration 12/2023 - 12/2019
2	Aftercare (After-Treatment) 04/2023 - 01/2020
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 07/2021
2	Immunotherapy 01/2021 - 01/2021
2	Subcutaneous Injections 05/2013 - 10/2012
1	Salvage Therapy 01/2021
1	Neoadjuvant Therapy 11/2020
1	Particle Accelerators 05/2020
1	Lasers (Laser) 10/2003